Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Forsteo ® (teriparatide)
Forsteo® (teriparatide): Short temporary Interruption
The recommended dose of Forsteo is 20 micrograms administered once daily. The impact of a short temporary interruption on clinical outcome is unknown.
Rate of compliance in the pivotal study
In the clinical trial investigating efficacy and safety in postmenopausal women with osteoporosis, the average rate of compliance with the regimen of injections, assessed on the basis of returned medication, ranged from 79 to 83 % at each visit.1
In result, the known efficacy has been established including a number of patients who have missed some injections. Whether or not efficacy was different in patients administering all injections versus patients missing some injections, is unknown.
Recommendation for forgotten or missed Injection
If you forget or cannot take Forsteo at your usual time, take it as soon as possible on that day.2
Do not take a double dose to make up for a forgotten dose.
Do not take more than one injection in the same day.
2. Forsteo [package leaflet]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: November 11, 2019